MYO News and Press, Myomo Inc. From 05/13/19

Myomo (NYSEMKT: MYO ): Q1 GAAP EPS of -$0.17 beats by $0.02 . More news on: Myomo, Inc., Earnings news and commentary, Healthcare stocks news, , Read more ...

Reports 165% Year-over-Year Revenue Growth and Continued Expansion of Reimbursement Pipeline Myomo, Inc. (NYSE American: MYO) (“Myomo” or the “Company”), a wearable medical robotics company that offers increased functionality for those suffering from neur...

Management to hold a conference call at 8:30 a.m. EDT Myomo, Inc. (NYSE American: MYO) (“Myomo” or the “Company”), a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper limb paralys...

Neuro Muscular Orthotics to Offer MyoPro ® Across a Huge New Geography Myomo, Inc. (NYSE American: MYO) (“Myomo” or the “Company”), a wearable medical robotics company that offers increased functionality for those suffering from neurol...

Myomo (NYSEMKT: MYO ) has signed an agreement with Tecnoplanta Orthopedic Laboratory with the goal of offering MyoPro in Chile. More news on: Myomo, Inc., Healthcare stocks news, Stocks on the move, Read more ...

Tecnoplanta Expands its Portfolio with MyoPro ® Myomo, Inc. (NYSE American: MYO) (“Myomo” or the “Company”), a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper lim...

Progettiamo Autonomia Robotics Expands its Portfolio with MyoPro ® Myomo, Inc. (NYSE American: MYO) (“Myomo” or the “Company”), a wearable medical robotics company that offers increased functionality for those suffering from neurological disorde...

Myomo, Inc. (NYSE American: MYO) (“Myomo” or the “Company”), a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper limb paralysis, today announced that, as previously disclosed in its Annu...

Myomo, Inc. (NYSE American: MYO) (“Myomo” or the “Company”), a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper limb paralysis, today announced that Chairman and Chief Executive Officer...

Myomo, Inc. (MYO) Q4 2018 Earnings Conference Call March 7, 2019 4:30 PM ET Company Participants Vivian Cervantes – Investor Relations Paul Gudonis – Chairman and Chief Executive Officer David Henry – Chief Financial Officer Conference Call Participants ...